A batch of Nicopass lozenges is being recalled due to a packaging error, which could pose an allergic risk to some users.
- Nicopass lozenges, a smoking cessation medicine, are being recalled due to a packaging error.
- The boxes concerned bear the batch reference number 4N4RH. The risk of nicotine overdose is minimal but there is an allergic risk for people allergic to soya.
- If you have one of these boxes, you must return it to the pharmacy to obtain another compliant one.
“We were informed on 17/07/2024 that packets of Nicopass fresh mint 2.5 mg sugar-free lozenges were mistakenly packed in boxes intended for Nicopass eucalyptus 1.5 mg sugar-free, 96 lozenges, batch no. 4N4RH“, noted the press release from the National Agency for the Safety of Medicines.
A packaging error that could lead to an allergic risk
“The potential risk of nicotine overdose is minimal“, specifies the agency. However, the presence of soybean oil in the composition of Nicopass mint freshness 2.5 mg sugar-free lozenges may pose a potential risk for people allergic to soy. “The risk of an allergic reaction occurring is low given the very limited number of boxes concerned.”, the statement added.
Return the Nicopass boxes from batch no. 4N4RH to the pharmacy
The boxes to be returned to the pharmacy were distributed between 06/11/2024 and 07/08/2024. To identify them, you must check whether the batch reference 4N4RH appears on the packaging. If this is the case, you must return the medicine to the pharmacy.Your pharmacist will check the batch number of your box and, if necessary, issue you with a new box from a compliant batch.”
Nicopass, a drug used to quit smoking
“Nicopass is a non-prescription medicine used to help adolescents aged 15 and over and adults quit smoking.”, developed by the Pierre Fabre laboratory. Please note, however, that without medical advice, this nicotine substitute should not be used by pregnant women and young people under 18. These are lozenges to be sucked until completely dissolved in the mouth, approximately 30 minutes. Do not exceed 30 lozenges per day (1.5 mg dosage) or 15 lozenges per day (2.5 mg dosage). The dosage depends on the person’s degree of nicotine dependence.
